Skin prick testing is a specialised test to detect specific IgE antibodies to a range of allergens.
The accuracy of the skin prick test is highly dependent on the expertise and experience of the individual performing it. There are a number of variables that can influence the result given it is an in-vivo test, unlike highly controlled in-vitro testing, and significant inter-operator variability has been documented.
To ensure operator competency, and by extension, accuracy of the test, each operator must regularly perform skin prick testing. Pathlab recently reviewed skin prick test numbers processed at it's Taupō site, and a minimum target of tests per operator per week was advised by their immunopathologist.
Due to the very low volume of skin prick tests processed at Pathlab Taupō, and in commitment to service quality, they have found it necessary to discontinue skin prick testing at this site. Patients will instead be booked for the same testing at a different site, the closest being Rotorua – OPD Department – Rotorua Hospital.
Reference:
View Pathlab skin prick test online request form and patient information sheet.
View Pathlab advice on appropriate use of this test.
Dr. Marianne Empson, Immunolopathologist
Andrew Soepnel, Service Lead Immunology
From 1 October 2024, invasive group A streptococcal infection (iGAS) has been added to Aotearoa New Zealand’s schedule of notifiable diseases. This places new legal requirements on health practitioners and laboratories for the management and reporting of both suspected and confirmed iGAS cases.
Read moreAntibiotic treatment for patients aged 15 years and older with moderate cellulitis funded by ACC. Oral antibiotic therapy is the preferred option.
View detailsThis BPAC resource assists to predict risk of serious illness in children with fever